BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3536700)

  • 21. [Clinical trials of urapidil. Review of human pharmacological studies with a summary of a multi-center study].
    Bruckschen EG; Henze F; Michael G
    Arzneimittelforschung; 1978; 28(7):1176-84. PubMed ID: 385007
    [No Abstract]   [Full Text] [Related]  

  • 22. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
    Lotti G; Gianrossi R
    Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women.
    Fan X; Wang Y; Sun K; Zhang W; Yang X; Wang S; Zhen Y; Wang J; Li W; Han Y; Liu T; Wang X; Chen J; Wu H; Hui R;
    Clin Pharmacol Ther; 2007 Aug; 82(2):187-96. PubMed ID: 17473847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baltimore awarded a clinical center for the study of systolic hypertension in the elderly.
    Entwisle G; Lewis C
    Md Med J; 1985 Apr; 34(4):347-8. PubMed ID: 3915528
    [No Abstract]   [Full Text] [Related]  

  • 25. [Does urapidil attenuate the hypertensive response to tracheal intubation at the time of general anesthesia?].
    Quéré JF; Ozier Y; Bringier J; Morot B; Bernard D; Pigot B; Conseiller C
    Cah Anesthesiol; 1990 Nov; 38(5):343-4. PubMed ID: 2285871
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
    Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Siegrist J; Broer M
    Ter Arkh; 1995; 67(9):45-50. PubMed ID: 7495042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].
    Madsen JL; Hvidt S
    Ugeskr Laeger; 1984 Sep; 146(36):2695-7. PubMed ID: 6393495
    [No Abstract]   [Full Text] [Related]  

  • 29. [European multicenter study of aged patients with arterial hypertension].
    De Schaepdryver A; Amery A
    Verh K Acad Geneeskd Belg; 1986; 48(2):109-24. PubMed ID: 3751255
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
    Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
    Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
    Malacco E; Piazza S; Carretta R; Di Somma S; Mugellini A; Bertocchi F; Palatini P;
    Int J Clin Pharmacol Ther; 2002 Jun; 40(6):263-9. PubMed ID: 12078940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Captopril Prevention Project (CAPPP): description and status.
    Hansson L
    Am J Hypertens; 1994 Sep; 7(9 Pt 2):82S-83S. PubMed ID: 7818840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial.
    Hu Y; Zhu J
    Chin Med J (Engl); 1999 Apr; 112(4):302-7. PubMed ID: 11593526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive therapy in elderly patients. Ninth interim report. The European Working Party on High Blood Pressure in the Elderly (EWPHE).
    Neth J Med; 1984; 27(4):165-70. PubMed ID: 6377103
    [No Abstract]   [Full Text] [Related]  

  • 37. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urapidil as a basic drug in severe hypertension].
    Thuma G
    Fortschr Med; 1986 Jun; 104(22):457-460. PubMed ID: 3744250
    [No Abstract]   [Full Text] [Related]  

  • 40. Overview of clinical trials with urapidil.
    Schook CE; Radtke H; Wurst W; Thieme G
    Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.